Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.
Press releases published on June 16, 2025
Banner Health names new chief supply chain officer
GlobeNewswire
·
June 16, 2025
Phoenix, June 16, 2025 (GLOBE NEWSWIRE) -- After more than two decades in health care supply chain management, Ryan Koos has joined Banner Health as senior vice president and chief supply chain officer. Koos will oversee all aspects of Banner’s health care …
Academy of Nutrition and Dietetics Leads Trusted Health Organizations in Urging Congress to Protect Investments in Nutrition Security
GlobeNewswire
·
June 16, 2025
Chicago, June 16, 2025 (GLOBE NEWSWIRE) -- The Academy of Nutrition and Dietetics, the world’s largest organization of food and nutrition professionals, sent a letter to key members of Congress on Friday, June 13, 2025, urging them to reject proposed cuts …
Disposable Ostomy Bags Market: Discovering the Next Major Healthcare Innovation
GlobeNewswire
·
June 16, 2025
Boston, June 16, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Disposable Ostomy Bags: Global Market” is projected to increase from $2.8 billion in 2024 to $3.7 billion by the end of 2031, at a compound annual growth rate ( …
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
GlobeNewswire
·
June 16, 2025
NEW HAVEN, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately today, no later than 11 pm Eastern …
Kiss the Ground Launches Free Regenerative Purchasing Guides to Inform and Inspire Shoppers
GlobeNewswire
·
June 16, 2025
LOS ANGELES, CA, June 16, 2025 (GLOBE NEWSWIRE) -- Kiss the Ground, a nonprofit organization dedicated to promoting regeneration and healthy soil as a viable solution for our wellness, water, and climate crisis, today announced the release of its …
FibroBiologics to Present at the BIO International Convention 2025
GlobeNewswire
·
June 16, 2025
HOUSTON, June 16, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic …
BioAro Launches PanOmiQ™ Research in Breakthrough for AI-Driven Drug Discovery and Multi-Omics
GlobeNewswire
·
June 16, 2025
AI meets genomics in BioAro’s latest launch, unlocking faster, scalable drug discovery. PanOmiQ™ Research sets a new global benchmark for precision health innovation. BOSTON, June 16, 2025 (GLOBE NEWSWIRE) -- BIO International Convention In a bold move …
Inquis Medical’s AVENTUS Thrombectomy System Receives FDA 510(k) Clearance for Treatment of Pulmonary Embolism
GlobeNewswire
·
June 16, 2025
MENLO PARK, Calif., June 16, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, the leading innovator in the treatment of venous thromboembolic disease, today announced that its AVENTUS Thrombectomy System has received 510(k) clearance from the U.S. Food and Drug …
BlueGenes and Levrx Partner to Integrate Real-Time Genetic Insights into the Pharmacy Benefit Experience
GlobeNewswire
·
June 16, 2025
SCOTTSDALE, Ariz., June 16, 2025 (GLOBE NEWSWIRE) -- BlueGenes, a leading pharmacogenetics (PGX) solution, and Levrx Technology, a digital pharmacy engagement platform, have announced a strategic partnership. Together they aim to accelerate the adoption of …
Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year
GlobeNewswire
·
June 16, 2025
BOSTON and LONDON, June 16, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the IND to initiate a Phase 1 clinical …
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
GlobeNewswire
·
June 16, 2025
LONDON and PHOENIX, June 16, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has …
Solera HALO™ Platform Adds Rapid Configurability Tool for Integrated Digital Health Networks
GlobeNewswire
·
June 16, 2025
PHOENIX, June 16, 2025 (GLOBE NEWSWIRE) -- Solera Health, the premier digital health delivery company offering affordable, accessible, and effective digital healthcare solutions, today announced enhancements to its HALO Platform. The latest enhancements …
Psychemedics Releases 2025 Workforce Insights Report
GlobeNewswire
·
June 16, 2025
DALLAS, June 16, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair testing for drugs of abuse, today announced the release of its second annual Workforce Insights Report, providing a comprehensive look at the evolving drug …
3Daughters to Lead Panel at BIO International Convention on Patient Reported Outcomes that Includes FDA Division Director
GlobeNewswire
·
June 16, 2025
BOSTON, June 16, 2025 (GLOBE NEWSWIRE) -- 3Daughters, Inc., a clinical development company fueling revolutionary healthcare for women, is proud to announce its founder and CEO, Mary Beth Cicero, will moderate a breakout session at this week’s annual BIO …
INVO Fertility’s Wisconsin Clinic Recognized on Newsweek’s List of America’s Best Fertility Clinics for 2025
GlobeNewswire
·
June 16, 2025
MIDDLETON, Wis. and SARASOTA, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on expanding access to advanced treatment through the establishment, …
Can-Fite to Present Phase IIa Pancreatic Cancer Study Progress During Partnering Meetings at the 2025 BIO International Convention in Boston
GlobeNewswire
·
June 16, 2025
Ramat Gan, Israel, June 16, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs for the treatment of cancer and inflammatory …
Bon Natural Life Announces Distribution Agreement with Tianjin Merrill-Youli Trading Co., Ltd.
GlobeNewswire
·
June 16, 2025
XI’AN, China, June 16, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“Bon” or the “Company”), a leading bio-ingredient solutions provider for natural, health, and personal care industries, today announced a non-exclusive sales …
SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company’s SSi Mantra 3 Surgical Robotic System
GlobeNewswire
·
June 16, 2025
FORT LAUDERDALE, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and …
Syncromune® Appoints Industry Veteran Kerri-Ann Millar as Chief Financial Officer to Advance Corporate Growth Initiatives and Clinical Development Program
GlobeNewswire
·
June 16, 2025
FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, June 16, 2025 (GLOBE NEWSWIRE) -- Syncromune® Inc., a clinical-stage biopharmaceutical company pioneering SYNC-T, an in situ personalized combination immunotherapy platform for solid tumor cancers, today …
Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology
GlobeNewswire
·
June 16, 2025
Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanoma Fosun Pharma-Teva collaboration agreement established with goal of accelerating clinical data generation for TEV- …